{"transactions":[{"id":4637624,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-10-08T01:00:03.000Z","date":"2026-10-05","kind":"grant","planned":false,"acquired":true,"shares":64000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person was granted this option pursuant to the 2026 Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2027 annual meeting of stockholders or October 5, 2027."}],"balance_after":64000,"derivative":{"exercise_price":3.75,"expiration_date":"2036-10-05","underlying":"Common Stock","underlying_shares":64000},"source":{"system":"sec-edgar","filing":"0001193125-26-417232","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312526417232/ownership.xml","form_type":"4"}},{"id":4637623,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-08T01:00:03.000Z","date":"2026-10-05","kind":"grant","planned":false,"acquired":true,"shares":10700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted this restricted stock unit award (RSU) pursuant to the 2026 Non-Employee Director Compensation Policy. The RSU vests as to 100% of the shares on the earlier of the Company's 2027 annual meeting of stockholders or October 5, 2027."}],"balance_after":23400,"source":{"system":"sec-edgar","filing":"0001193125-26-417232","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312526417232/ownership.xml","form_type":"4"}},{"id":4619202,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-16T20:06:20.000Z","date":"2026-09-15","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":7.081,"value":35405.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.074 to $7.085, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":19310,"source":{"system":"sec-edgar","filing":"0001628280-26-062239","document":"wk-form4_1789589178.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026062239/wk-form4_1789589178.xml","form_type":"4"}},{"id":737628,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-15T21:05:59.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Program, which became effective on June 11, 2026, the RSUs shall vest on the earlier of June 11, 2027 or the day immediately prior to the date of the next Annual Meeting occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Program, which became effective on June 11, 2026, the RSUs shall vest on the earlier of June 11, 2027 or the day immediately prior to the date of the next Annual Meeting occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such vesting date."}],"balance_after":25000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001628280-26-043299","document":"wk-form4_1781557557.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000162828026043299/wk-form4_1781557557.xml","form_type":"4"}},{"id":861134,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T22:55:22.000Z","date":"2026-03-03","kind":"sale","planned":false,"acquired":false,"shares":12497,"price":1.514,"value":18920.458,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares mandatorily sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This sale price represents the weighted average sale price of the shares sold ranging from $1.49 to $1.56 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4."}],"balance_after":3581813,"source":{"system":"sec-edgar","filing":"0001299130-26-000043","document":"wk-form4_1772664920.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913026000043/wk-form4_1772664920.xml","form_type":"4"}},{"id":866185,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-03T23:11:11.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":1841621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in 36 equal monthly installments beginning on March 27, 2026, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates."}],"balance_after":1841621,"derivative":{"exercise_price":1.68,"expiration_date":"2036-02-27","underlying":"Common Stock","underlying_shares":1841621},"source":{"system":"sec-edgar","filing":"0001299130-26-000037","document":"wk-form4_1772579469.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913026000037/wk-form4_1772579469.xml","form_type":"4"}},{"id":866184,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-03T23:11:11.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":920810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\"). The RSUs will vest in equal annual installments on February 15 of each of 2027, 2028, and 2029, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates."}],"balance_after":3594310,"source":{"system":"sec-edgar","filing":"0001299130-26-000037","document":"wk-form4_1772579469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913026000037/wk-form4_1772579469.xml","form_type":"4"}},{"id":893050,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-20T01:31:39.000Z","date":"2026-02-18","kind":"sale","planned":false,"acquired":false,"shares":140874,"price":1.629,"value":229483.746,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares mandatorily sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This sale price represents the weighted average sale price of the shares sold ranging from $1.55 to $1.70 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4."}],"balance_after":2673500,"source":{"system":"sec-edgar","filing":"0001299130-26-000021","document":"wk-form4_1771551097.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913026000021/wk-form4_1771551097.xml","form_type":"4"}},{"id":893049,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-20T01:31:39.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":331793,"price":1.576,"value":522905.768,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares mandatorily sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This sale price represents the weighted average sale price of the shares sold ranging from $1.51 to $1.68 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4."}],"balance_after":2814374,"source":{"system":"sec-edgar","filing":"0001299130-26-000021","document":"wk-form4_1771551097.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913026000021/wk-form4_1771551097.xml","form_type":"4"}},{"id":974313,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-12-11T02:45:12.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These share options are fully vested."}],"balance_after":15000,"derivative":{"exercise_price":4.585,"expiration_date":"2028-08-07","underlying":"Ordinary Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001193125-25-314740","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000119312525314740/ownership.xml","form_type":"4"}},{"id":974312,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-12-11T02:45:12.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These share options are fully vested."}],"balance_after":6000,"derivative":{"exercise_price":3.5,"expiration_date":"2027-08-15","underlying":"Ordinary Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193125-25-314740","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000119312525314740/ownership.xml","form_type":"4"}},{"id":974311,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-12-11T02:45:12.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":false,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These share options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.97,"expiration_date":"2026-08-16","underlying":"Ordinary Shares","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001193125-25-314740","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000119312525314740/ownership.xml","form_type":"4"}},{"id":974310,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:12.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":30000,"price":18.02,"value":540600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $18.00 to $18.19 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":12700,"source":{"system":"sec-edgar","filing":"0001193125-25-314740","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000119312525314740/ownership.xml","form_type":"4"}},{"id":974309,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:12.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":true,"shares":30000,"price":4.585,"value":137550.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025."}],"balance_after":42700,"source":{"system":"sec-edgar","filing":"0001193125-25-314740","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000119312525314740/ownership.xml","form_type":"4"}},{"id":974308,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:12.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":14.07,"value":211050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $14.00 to $14.14 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":12700,"source":{"system":"sec-edgar","filing":"0001193125-25-314740","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000119312525314740/ownership.xml","form_type":"4"}},{"id":974307,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:12.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":3.5,"value":52500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025."}],"balance_after":27700,"source":{"system":"sec-edgar","filing":"0001193125-25-314740","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000119312525314740/ownership.xml","form_type":"4"}},{"id":974306,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:12.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":42000,"price":12.75,"value":535500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025."}],"balance_after":12700,"source":{"system":"sec-edgar","filing":"0001193125-25-314740","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000119312525314740/ownership.xml","form_type":"4"}},{"id":974305,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:12.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":true,"shares":42000,"price":5.97,"value":250740.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025."}],"balance_after":54700,"source":{"system":"sec-edgar","filing":"0001193125-25-314740","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000119312525314740/ownership.xml","form_type":"4"}},{"id":974304,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:12.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":6445,"price":12.75,"value":82173.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025."}],"balance_after":12700,"source":{"system":"sec-edgar","filing":"0001193125-25-314740","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000119312525314740/ownership.xml","form_type":"4"}},{"id":1043890,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-09-10T20:06:35.000Z","date":"2025-09-09","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":11.06,"value":110600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.97 to $11.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":24310,"source":{"system":"sec-edgar","filing":"0001263805-25-000007","document":"wk-form4_1757534793.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000126380525000007/wk-form4_1757534793.xml","form_type":"4"}},{"id":1043889,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-09-10T20:06:35.000Z","date":"2025-09-08","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":10.92,"value":109200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.91 to $11.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":34310,"source":{"system":"sec-edgar","filing":"0001263805-25-000007","document":"wk-form4_1757534793.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000126380525000007/wk-form4_1757534793.xml","form_type":"4"}},{"id":1067670,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-08-14T00:00:08.000Z","date":"2025-08-11","kind":"grant","planned":true,"acquired":true,"shares":76200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted this option pursuant to the 2025 Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2026 annual general meeting or August 11, 2026"}],"balance_after":76200,"derivative":{"exercise_price":8.105,"expiration_date":"2030-08-11","underlying":"Ordinary Shares","underlying_shares":76200},"source":{"system":"sec-edgar","filing":"0000950170-25-108287","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000095017025108287/ownership.xml","form_type":"4"}},{"id":1067669,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-14T00:00:08.000Z","date":"2025-08-13","kind":"sale","planned":true,"acquired":false,"shares":9670,"price":8.81,"value":85192.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 24, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $8.45 to $9.03 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":29645,"source":{"system":"sec-edgar","filing":"0000950170-25-108287","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000095017025108287/ownership.xml","form_type":"4"}},{"id":1067668,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-14T00:00:08.000Z","date":"2025-08-11","kind":"grant","planned":true,"acquired":true,"shares":12700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted this restricted share unit award (RSU) pursuant to the 2025 Non-Employee Director Compensation Policy. The RSU vests as to 100% of the shares on the earlier of the Company's 2026 annual general meeting or August 11, 2026."}],"balance_after":39315,"source":{"system":"sec-edgar","filing":"0000950170-25-108287","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000095017025108287/ownership.xml","form_type":"4"}},{"id":1111349,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true}}],"security":"Stock Option","published_at":"2025-06-13T20:11:01.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":34375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"In accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Program, which became effective on June 12, 2025, the option shall vest and become exercisable in substantially equal installments on each of the first three anniversaries of the date of grant, such that the option shall be fully vested on the third anniversary of the date of grant, subject to the Non-Employee Director continuing in service as a Non-Employee Director through each such vesting date."}],"balance_after":34375,"derivative":{"exercise_price":9.29,"expiration_date":"2035-06-12","underlying":"Class A Common Stock","underlying_shares":34375},"source":{"system":"sec-edgar","filing":"0001127602-25-017479","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000112760225017479/form4.xml","form_type":"4"}},{"id":1111348,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-06-13T20:11:01.000Z","date":"2025-06-11","kind":"exercise","planned":false,"acquired":false,"shares":10822,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In accordance with the Issuer's Non-Employee Director Compensation Program, the RSUs granted on June 13, 2024 vested in full in Class A shares on June 11, 2025, which was the day immediately prior to the date of the Issuer's next Annual Meeting of Shareholders occurring after the grant date, and was subject to the Reporting Person continuing in service as a Non-Employee Director of the Issuer through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In accordance with the Issuer's Non-Employee Director Compensation Program, the RSUs granted on June 13, 2024 vested in full in Class A shares on June 11, 2025, which was the day immediately prior to the date of the Issuer's next Annual Meeting of Shareholders occurring after the grant date, and was subject to the Reporting Person continuing in service as a Non-Employee Director of the Issuer through such date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":10822},"source":{"system":"sec-edgar","filing":"0001127602-25-017479","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000112760225017479/form4.xml","form_type":"4"}},{"id":1111347,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2025-06-13T20:11:01.000Z","date":"2025-06-11","kind":"exercise","planned":false,"acquired":true,"shares":10822,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":44310,"source":{"system":"sec-edgar","filing":"0001127602-25-017479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000112760225017479/form4.xml","form_type":"4"}},{"id":1194529,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-03-22T01:00:05.000Z","date":"2025-03-20","kind":"exercise","planned":true,"acquired":false,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These share options are fully vested and have an expiration date of August 18, 2025."}],"balance_after":0,"derivative":{"exercise_price":9.13,"expiration_date":"2025-08-18","underlying":"Ordinary Shares","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0000950170-25-043440","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000095017025043440/ownership.xml","form_type":"4"}},{"id":1194528,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-03-22T01:00:05.000Z","date":"2025-03-20","kind":"sale","planned":true,"acquired":false,"shares":10500,"price":9.769,"value":102574.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 24, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $9.69 to $9.88 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":16115,"source":{"system":"sec-edgar","filing":"0000950170-25-043440","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000095017025043440/ownership.xml","form_type":"4"}},{"id":1194527,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-03-22T01:00:05.000Z","date":"2025-03-20","kind":"exercise","planned":true,"acquired":true,"shares":10500,"price":9.13,"value":95865.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 24, 2024."}],"balance_after":26615,"source":{"system":"sec-edgar","filing":"0000950170-25-043440","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000095017025043440/ownership.xml","form_type":"4"}},{"id":1194533,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-21T20:52:55.000Z","date":"2025-03-19","kind":"grant","planned":false,"acquired":true,"shares":1841621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in 24 equal monthly installments beginning on March 15, 2025, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates."}],"balance_after":1841621,"derivative":{"exercise_price":1.25,"expiration_date":"2035-03-19","underlying":"Common Stock","underlying_shares":1841621},"source":{"system":"sec-edgar","filing":"0001299130-25-000067","document":"wk-form4_1742590368.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913025000067/wk-form4_1742590368.xml","form_type":"4"}},{"id":1194532,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-21T20:52:55.000Z","date":"2025-03-19","kind":"grant","planned":false,"acquired":true,"shares":920810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\"). The RSUs will vest in equal annual installments on February 15 of each of 2026 and 2027, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates."}],"balance_after":3146167,"source":{"system":"sec-edgar","filing":"0001299130-25-000067","document":"wk-form4_1742590368.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913025000067/wk-form4_1742590368.xml","form_type":"4"}},{"id":1222070,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-05T21:37:39.000Z","date":"2025-03-03","kind":"sale","planned":false,"acquired":false,"shares":12497,"price":1.407,"value":17583.279,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This sale price represents the weighted average sale price of the shares sold ranging from $1.39 to $1.46 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4."}],"balance_after":2225357,"source":{"system":"sec-edgar","filing":"0001299130-25-000048","document":"wk-form4_1741210653.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913025000048/wk-form4_1741210653.xml","form_type":"4"}},{"id":1259378,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-19T21:58:57.000Z","date":"2025-02-18","kind":"sale","planned":false,"acquired":false,"shares":259909,"price":1.878,"value":488109.102,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This sale price represents the weighted average sale price of the shares sold ranging from $1.80 to $2.00 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4."}],"balance_after":2237854,"source":{"system":"sec-edgar","filing":"0001299130-25-000037","document":"wk-form4_1740002329.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913025000037/wk-form4_1740002329.xml","form_type":"4"}},{"id":1404951,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-09-17T20:11:25.000Z","date":"2024-09-16","kind":"sale","planned":false,"acquired":false,"shares":98907,"price":1.746,"value":172691.622,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This sale price represents the weighted average sale price of the shares sold ranging from $1.69 to $1.84 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4."}],"balance_after":2497763,"source":{"system":"sec-edgar","filing":"0001299130-24-000175","document":"wk-form4_1726603872.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913024000175/wk-form4_1726603872.xml","form_type":"4"}},{"id":1433496,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2024-08-14T22:00:07.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":32230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person was granted this option pursuant to the 2024 Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2025 annual general meeting or August 12, 2025."}],"balance_after":32230,"derivative":{"exercise_price":5.37,"expiration_date":"2029-08-12","underlying":"Ordinary Shares","underlying_shares":32230},"source":{"system":"sec-edgar","filing":"0000950170-24-097287","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000095017024097287/ownership.xml","form_type":"4"}},{"id":1433495,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-08-14T22:00:07.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":16115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted this restricted share unit award (RSU) pursuant to the 2024 Non-Employee Director Compensation Policy. The RSU vests as to 100% of the shares on the earlier of the Company's 2025 annual general meeting or August 12, 2025."}],"balance_after":16115,"source":{"system":"sec-edgar","filing":"0000950170-24-097287","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000095017024097287/ownership.xml","form_type":"4"}},{"id":1478798,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true}}],"security":"Stock Option","published_at":"2024-06-14T20:30:24.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":571428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"In accordance with the Issuer's Non-Employee Director Compensation Program, the Black-Scholes value of the option award as of the grant date is $200,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The vesting date of the RSUs and stock options, and in the case of the stock options the date they become exercisable, will be the earlier of (i) June 13, 2025 or (ii) the day immediately prior to the date of the Issuer's next Annual Meeting of Shareholders occurring after the grant date, in either case subject to the Reporting Person continuing in service as a Non-Employee Director of the Issuer through such date. The RSUs have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"In accordance with the Issuer's Non-Employee Director Compensation Program, the Black-Scholes value of the option award as of the grant date is $200,000."}],"balance_after":571428,"derivative":{"exercise_price":0.462,"expiration_date":"2034-06-13","underlying":"Class A Common Stock","underlying_shares":571428},"source":{"system":"sec-edgar","filing":"0001127602-24-018730","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000112760224018730/form4.xml","form_type":"4"}},{"id":1478797,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-06-14T20:30:24.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":432900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The vesting date of the RSUs and stock options, and in the case of the stock options the date they become exercisable, will be the earlier of (i) June 13, 2025 or (ii) the day immediately prior to the date of the Issuer's next Annual Meeting of Shareholders occurring after the grant date, in either case subject to the Reporting Person continuing in service as a Non-Employee Director of the Issuer through such date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The vesting date of the RSUs and stock options, and in the case of the stock options the date they become exercisable, will be the earlier of (i) June 13, 2025 or (ii) the day immediately prior to the date of the Issuer's next Annual Meeting of Shareholders occurring after the grant date, in either case subject to the Reporting Person continuing in service as a Non-Employee Director of the Issuer through such date. The RSUs have no expiration date."}],"balance_after":432900,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":432900},"source":{"system":"sec-edgar","filing":"0001127602-24-018730","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000112760224018730/form4.xml","form_type":"4"}},{"id":1478796,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-06-14T20:30:24.000Z","date":"2024-06-12","kind":"exercise","planned":false,"acquired":false,"shares":105263,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In accordance with the Issuer's Non-Employee Director Compensation Program, the RSUs granted on June 16, 2023 vested in full in Class A shares on June 12, 2024, which was the day immediately prior to the date of the Issuer's next Annual Meeting of Shareholders occurring after the grant date, and was subject to the Reporting Person continuing in service as a Non-Employee Director of the Issuer through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In accordance with the Issuer's Non-Employee Director Compensation Program, the RSUs granted on June 16, 2023 vested in full in Class A shares on June 12, 2024, which was the day immediately prior to the date of the Issuer's next Annual Meeting of Shareholders occurring after the grant date, and was subject to the Reporting Person continuing in service as a Non-Employee Director of the Issuer through such date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":105263},"source":{"system":"sec-edgar","filing":"0001127602-24-018730","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000112760224018730/form4.xml","form_type":"4"}},{"id":1478795,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2024-06-14T20:30:24.000Z","date":"2024-06-12","kind":"exercise","planned":false,"acquired":true,"shares":105263,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":1339641,"source":{"system":"sec-edgar","filing":"0001127602-24-018730","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000112760224018730/form4.xml","form_type":"4"}},{"id":1591332,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-03-06T22:12:21.000Z","date":"2024-03-04","kind":"sale","planned":false,"acquired":false,"shares":14177,"price":4.871,"value":69056.167,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This sale price represents the weighted average sale price of the shares sold ranging from $4.72 to $5.22 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4."}],"balance_after":2596670,"source":{"system":"sec-edgar","filing":"0001299130-24-000068","document":"wk-form4_1709763127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913024000068/wk-form4_1709763127.xml","form_type":"4"}},{"id":1619039,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-26T21:59:45.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":1605769,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\"). The RSUs will vest in equal annual installments on February 15th of each of 2025, 2026, 2027, and 2028, provided that the Reporting Person continues to serve through each applicable vesting date."}],"balance_after":2610847,"source":{"system":"sec-edgar","filing":"0001299130-24-000046","document":"wk-form4_1708984765.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913024000046/wk-form4_1708984765.xml","form_type":"4"}},{"id":1628634,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-21T23:14:01.000Z","date":"2024-02-20","kind":"sale","planned":false,"acquired":false,"shares":1979,"price":5.261,"value":10411.519,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This sale price represents the weighted average sale price of the shares sold ranging from $5.09 to $5.76 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4."}],"balance_after":1005078,"source":{"system":"sec-edgar","filing":"0001299130-24-000023","document":"wk-form4_1708557177.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913024000023/wk-form4_1708557177.xml","form_type":"4"}},{"id":1628633,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-21T23:14:01.000Z","date":"2024-02-16","kind":"sale","planned":false,"acquired":false,"shares":79038,"price":5.958,"value":470908.404,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This sale price represents the weighted average sale price of the shares sold ranging from $5.69 to $6.65 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4."}],"balance_after":1007057,"source":{"system":"sec-edgar","filing":"0001299130-24-000023","document":"wk-form4_1708557177.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913024000023/wk-form4_1708557177.xml","form_type":"4"}},{"id":1709055,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-12-15T21:35:20.000Z","date":"2023-12-14","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":10,"value":200000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was made pursuant to a 10b5-1 plan, as adopted on May 18, 2023."}],"balance_after":1086095,"source":{"system":"sec-edgar","filing":"0001299130-23-000145","document":"wk-form4_1702676106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913023000145/wk-form4_1702676106.xml","form_type":"4"}},{"id":1748498,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2023-11-06T22:23:32.000Z","date":"2023-11-02","kind":"sale","planned":true,"acquired":false,"shares":4500,"price":1.39,"value":6255.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares sold by the Reporting Person pursuant to a 10b5-1 plan to cover such individual's estimated tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":1234378,"source":{"system":"sec-edgar","filing":"0001127602-23-026865","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000112760223026865/form4.xml","form_type":"4"}},{"id":1763410,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2023-10-06T21:03:17.000Z","date":"2023-10-02","kind":"sale","planned":true,"acquired":false,"shares":4499,"price":1.78,"value":8008.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares sold by the Reporting Person pursuant to a 10b5-1 plan to cover such individual's estimated tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":1238878,"source":{"system":"sec-edgar","filing":"0001127602-23-025684","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000112760223025684/form4a.xml","form_type":"4/A","original_submission_date":"2023-10-04"}},{"id":1765103,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2023-10-04T21:21:44.000Z","date":"2023-10-02","kind":"sale","planned":true,"acquired":false,"shares":4499,"price":4499,"value":20241001.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares sold by the Reporting Person pursuant to a 10b5-1 plan to cover such individual's estimated tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":1238878,"source":{"system":"sec-edgar","filing":"0001127602-23-025520","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000112760223025520/form4.xml","form_type":"4"}},{"id":1777179,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-09-19T20:32:00.000Z","date":"2023-09-18","kind":"sale","planned":false,"acquired":false,"shares":96844,"price":10.122,"value":980254.968,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This sale price represents the weighted average sale price of the shares sold ranging from $10.01 to $10.34 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4."}],"balance_after":1106095,"source":{"system":"sec-edgar","filing":"0001299130-23-000115","document":"wf-form4_169515550150177.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913023000115/wf-form4_169515550150177.xml","form_type":"4"}},{"id":1782820,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-09-12T20:42:08.000Z","date":"2023-09-11","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":10.452,"value":104520.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was made pursuant to a 10b5-1 plan, as adopted on May 18, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This sale price represents the weighted average sale price of the shares sold ranging from $10.33 to $10.64 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4."}],"balance_after":1202939,"source":{"system":"sec-edgar","filing":"0001299130-23-000113","document":"wf-form4_169455131313168.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913023000113/wf-form4_169455131313168.xml","form_type":"4"}},{"id":1786880,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2023-09-06T21:05:31.000Z","date":"2023-09-05","kind":"sale","planned":true,"acquired":false,"shares":4499,"price":2.23,"value":10032.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares sold by the Reporting Person pursuant to a 10b5-1 plan to cover such individual's estimated tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":1243377,"source":{"system":"sec-edgar","filing":"0001127602-23-023814","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000112760223023814/form4.xml","form_type":"4"}},{"id":1801762,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-08-18T20:44:18.000Z","date":"2023-08-17","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":10.5,"value":105000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was made pursuant to a 10b5-1 plan, as adopted on May 18, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This sale price represents the weighted average sale price of the shares sold ranging from $10.39 to $10.63 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4."}],"balance_after":1212939,"source":{"system":"sec-edgar","filing":"0001299130-23-000111","document":"wf-form4_169239144206224.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913023000111/wf-form4_169239144206224.xml","form_type":"4"}},{"id":1811852,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2023-08-10T00:00:11.000Z","date":"2023-08-07","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2024 annual general meeting or August 7, 2024."}],"balance_after":45000,"derivative":{"exercise_price":4.58,"expiration_date":"2028-08-07","underlying":"Ordinary Shares","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0000899243-23-017911","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000089924323017911/doc4.xml","form_type":"4"}},{"id":1814787,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2023-08-04T21:07:07.000Z","date":"2023-08-02","kind":"sale","planned":true,"acquired":false,"shares":4499,"price":2.25,"value":10122.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares sold by the Reporting Person pursuant to a 10b5-1 plan to cover such individual's estimated tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":1247876,"source":{"system":"sec-edgar","filing":"0001127602-23-022032","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000112760223022032/form4.xml","form_type":"4"}},{"id":1833623,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2023-07-06T21:04:30.000Z","date":"2023-07-03","kind":"sale","planned":true,"acquired":false,"shares":4499,"price":1.89,"value":8503.11,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares sold by the Reporting Person pursuant to a 10b5-1 plan to cover such individual's estimated tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":1252375,"source":{"system":"sec-edgar","filing":"0001127602-23-020425","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000112760223020425/form4.xml","form_type":"4"}},{"id":1847664,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true}}],"security":"Stock Option","published_at":"2023-06-21T21:06:29.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":139860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"In accordance with the Issuer's Non-Employee Director Compensation Program, the Black-Scholes value of the option award as of the grant date is $200,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The vesting date of the RSUs and stock options, and in the case of the stock options the date they become exercisable, will be the earlier of (i) June 16, 2024 or (ii) the day immediately prior to the date of the Issuer's next Annual Meeting of Shareholders occurring after the grant date, in either case subject to the Reporting Person continuing in service as a Non-Employee Director of the Issuer through such date.  The RSUs have no expiration date.  RSUs granted on June 10, 2022 that were initially reported as Class A Common Stock in Table I of a Form 4 dated June 13, 2022 vested in full in shares on June 10, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"In accordance with the Issuer's Non-Employee Director Compensation Program, the Black-Scholes value of the option award as of the grant date is $200,000."}],"balance_after":139860,"derivative":{"exercise_price":1.9,"expiration_date":"2033-06-16","underlying":"Class A Common Stock","underlying_shares":139860},"source":{"system":"sec-edgar","filing":"0001127602-23-019170","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000112760223019170/form4.xml","form_type":"4"}},{"id":1847663,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-06-21T21:06:29.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":105263,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The vesting date of the RSUs and stock options, and in the case of the stock options the date they become exercisable, will be the earlier of (i) June 16, 2024 or (ii) the day immediately prior to the date of the Issuer's next Annual Meeting of Shareholders occurring after the grant date, in either case subject to the Reporting Person continuing in service as a Non-Employee Director of the Issuer through such date.  The RSUs have no expiration date.  RSUs granted on June 10, 2022 that were initially reported as Class A Common Stock in Table I of a Form 4 dated June 13, 2022 vested in full in shares on June 10, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The vesting date of the RSUs and stock options, and in the case of the stock options the date they become exercisable, will be the earlier of (i) June 16, 2024 or (ii) the day immediately prior to the date of the Issuer's next Annual Meeting of Shareholders occurring after the grant date, in either case subject to the Reporting Person continuing in service as a Non-Employee Director of the Issuer through such date.  The RSUs have no expiration date.  RSUs granted on June 10, 2022 that were initially reported as Class A Common Stock in Table I of a Form 4 dated June 13, 2022 vested in full in shares on June 10, 2023."}],"balance_after":105263,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":105263},"source":{"system":"sec-edgar","filing":"0001127602-23-019170","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000112760223019170/form4.xml","form_type":"4"}},{"id":1855702,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2023-06-14T21:09:37.000Z","date":"2023-06-12","kind":"sale","planned":true,"acquired":false,"shares":39007,"price":1.84,"value":71772.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares sold by the Reporting Person pursuant to a 10b5-1 plan to cover such individual's estimated tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":1256874,"source":{"system":"sec-edgar","filing":"0001127602-23-018722","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000112760223018722/form4.xml","form_type":"4"}},{"id":1864990,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2023-06-06T21:02:42.000Z","date":"2023-06-02","kind":"sale","planned":true,"acquired":false,"shares":4499,"price":1.63,"value":7333.37,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares sold by the Reporting Person pursuant to a 10b5-1 plan to cover such individual's estimated tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":1295881,"source":{"system":"sec-edgar","filing":"0001127602-23-018067","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000112760223018067/form4.xml","form_type":"4"}},{"id":1904227,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2023-05-05T00:20:18.000Z","date":"2023-05-02","kind":"sale","planned":true,"acquired":false,"shares":4499,"price":1.16,"value":5218.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares sold by the Reporting Person pursuant to a 10b5-1 plan to cover such individual's estimated tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person pursuant to a 10b5-1 plan to cover such individual's estimated tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":1300380,"source":{"system":"sec-edgar","filing":"0001127602-23-014603","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000112760223014603/form4.xml","form_type":"4"}},{"id":1924800,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2023-04-05T22:41:46.000Z","date":"2023-04-03","kind":"sale","planned":true,"acquired":false,"shares":4499,"price":1.32,"value":5938.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares sold by the Reporting Person pursuant to a 10b5-1 plan to cover such individual's estimated tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person pursuant to a 10b5-1 plan to cover such individual's estimated tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":1304879,"source":{"system":"sec-edgar","filing":"0001127602-23-012627","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000112760223012627/form4.xml","form_type":"4"}},{"id":1949859,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2023-03-16T21:37:03.000Z","date":"2023-03-14","kind":"sale","acquired":false,"shares":4499,"price":1.37,"value":6163.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares sold by the Reporting Person pursuant to a 10b5-1 plan to cover such individual's estimated tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person pursuant to a 10b5-1 plan to cover such individual's estimated tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":1309378,"source":{"system":"sec-edgar","filing":"0001127602-23-010472","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000112760223010472/form4.xml","form_type":"4"}},{"id":1968733,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-03-06T21:53:38.000Z","date":"2023-03-03","kind":"sale","acquired":false,"shares":13769,"price":9.493,"value":130709.117,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This sale price represents the weighted average sale price of the shares sold ranging from $9.24 to $9.71 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4."}],"balance_after":1222939,"source":{"system":"sec-edgar","filing":"0001299130-23-000042","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913023000042/certent-form4.xml","form_type":"4"}},{"id":1968732,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-03-06T21:53:38.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":594687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\"). The RSUs will vest in equal annual installments on February 15th of each of 2024, 2025, 2026, and 2027, provided that the Reporting Person continues to serve through each applicable vesting date."}],"balance_after":1236708,"source":{"system":"sec-edgar","filing":"0001299130-23-000042","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913023000042/certent-form4.xml","form_type":"4"}},{"id":1999350,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-02-22T12:34:19.000Z","date":"2023-02-17","kind":"sale","acquired":false,"shares":1530,"price":10.271,"value":15714.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This sale price represents the weighted average sale price of the shares sold ranging from $9.80 to $10.82 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4."}],"balance_after":642021,"source":{"system":"sec-edgar","filing":"0001299130-23-000024","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913023000024/certent-form4.xml","form_type":"4"}},{"id":2032604,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2023-02-03T22:15:08.000Z","date":"2023-02-02","kind":"sale","acquired":false,"shares":4499,"price":2.1,"value":9447.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares sold by the Reporting Person pursuant to a 10b5-1 plan to cover such individual's estimated tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person pursuant to a 10b5-1 plan to cover such individual's estimated tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":1313877,"source":{"system":"sec-edgar","filing":"0001127602-23-003394","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000112760223003394/form4.xml","form_type":"4"}},{"id":2060184,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2023-01-06T23:21:38.000Z","date":"2023-01-04","kind":"sale","acquired":false,"shares":4499,"price":1.57,"value":7063.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares sold by the Reporting Person pursuant to a 10b5-1 plan to cover such individual's estimated tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person pursuant to a 10b5-1 plan to cover such individual's estimated tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":1318376,"source":{"system":"sec-edgar","filing":"0001127602-23-001102","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000112760223001102/form4.xml","form_type":"4"}},{"id":2095849,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-12-06T02:10:28.000Z","date":"2022-12-02","kind":"sale","acquired":false,"shares":4499,"price":1.85,"value":8323.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares sold by the Reporting Person pursuant to a 10b5-1 plan to cover such individual's estimated tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person pursuant to a 10b5-1 plan to cover such individual's estimated tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":1322875,"source":{"system":"sec-edgar","filing":"0000899243-22-037726","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000089924322037726/doc4.xml","form_type":"4"}},{"id":2098022,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-12-02T21:47:02.000Z","date":"2022-12-01","kind":"sale","acquired":false,"shares":45000,"price":10.844,"value":487980.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This sale price represents the weighted average sale price of the shares sold ranging from $10.76 to $10.96 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4."}],"balance_after":643551,"source":{"system":"sec-edgar","filing":"0001299130-22-000139","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913022000139/certent-form4.xml","form_type":"4"}},{"id":2123336,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-11-08T02:33:54.000Z","date":"2022-11-03","kind":"sale","acquired":false,"shares":49490,"price":2.56,"value":126694.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares sold by the Reporting Person pursuant to a 10b5-1 plan to cover such individual's estimated tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person pursuant to a 10b5-1 plan to cover such individual's estimated tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":1327374,"source":{"system":"sec-edgar","filing":"0000899243-22-035325","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000089924322035325/doc4.xml","form_type":"4"}},{"id":2155457,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-09-19T23:17:15.000Z","date":"2022-09-15","kind":"sale","acquired":false,"shares":91307,"price":5.7765,"value":527434.8855,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This sale price represents the weighted average sale price of the shares sold ranging from $5.67 to $5.93 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4."}],"balance_after":688551,"source":{"system":"sec-edgar","filing":"0001299130-22-000112","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913022000112/certent-form4.xml","form_type":"4"}},{"id":2181327,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2022-08-18T00:01:25.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2023 annual general meeting or August 15, 2023."}],"balance_after":21000,"derivative":{"exercise_price":3.5,"expiration_date":"2027-08-15","underlying":"Ordinary Shares","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0000899243-22-029099","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000089924322029099/doc4.xml","form_type":"4"}},{"id":2233897,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-06-14T01:15:53.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":108516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"In accordance with the Non-Employee Director Compensation Policy of the Issuer, the Black-Scholes value of the option award as of the grant date is $200,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The vesting date of the restricted stock units and stock options, and in the case of the stock options, the exercise date, will be the earlier of either June 10, 2023 or the day immediately prior to the date of the next Annual Meeting of Shareholders of the Issuer occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such date."}],"balance_after":108516,"derivative":{"exercise_price":2.82,"expiration_date":"2032-06-10","underlying":"Class A Common Stock","underlying_shares":108516},"source":{"system":"sec-edgar","filing":"0000899243-22-022289","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000089924322022289/doc4.xml","form_type":"4"}},{"id":2233896,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-06-14T01:15:53.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":70921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The vesting date of the restricted stock units and stock options, and in the case of the stock options, the exercise date, will be the earlier of either June 10, 2023 or the day immediately prior to the date of the next Annual Meeting of Shareholders of the Issuer occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such date."}],"balance_after":1376864,"source":{"system":"sec-edgar","filing":"0000899243-22-022289","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000089924322022289/doc4.xml","form_type":"4"}},{"id":2335182,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-03-15T01:34:15.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":1071395,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person was previously granted awards of restricted stock units covering Class A Common Stock, which vest based upon the Issuer's achievement of an event condition (i.e., an underwritten initial public offering or a change in control), subject to additional time based vesting conditions in accordance with the terms of the award.  On March 11, 2022, the Compensation Committee of the Issuer's Board of Directors, after consideration of the completion of the initial business combination, modified the event condition, resulting in the immediate vesting of 883,253 restricted stock units for which the time based vesting requirements had been satisfied as of December 31, 2021 and the issuance of a corresponding number of shares of Class A Common Stock. The remaining restricted stock units will continue to vest in accordance with the terms of the award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was previously granted awards of restricted stock units covering Class A Common Stock, which vest based upon the Issuer's achievement of an event condition (i.e., an underwritten initial public offering or a change in control), subject to additional time based vesting conditions in accordance with the terms of the award.  On March 11, 2022, the Compensation Committee of the Issuer's Board of Directors, after consideration of the completion of the initial business combination, modified the event condition, resulting in the immediate vesting of 883,253 restricted stock units for which the time based vesting requirements had been satisfied as of December 31, 2021 and the issuance of a corresponding number of shares of Class A Common Stock. The remaining restricted stock units will continue to vest in accordance with the terms of the award."}],"balance_after":1305943,"source":{"system":"sec-edgar","filing":"0000899243-22-010988","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000089924322010988/doc4.xml","form_type":"4"}},{"id":2350012,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-05T00:21:18.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":642300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal monthly installments over the next four years, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates."}],"balance_after":642300,"derivative":{"exercise_price":11.7,"exercise_date":"2022-04-02","expiration_date":"2032-03-02","underlying":"Common Stock","underlying_shares":642300},"source":{"system":"sec-edgar","filing":"0001299130-22-000033","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913022000033/certent-form4.xml","form_type":"4"}},{"id":2350011,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-03-05T00:21:18.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":107500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\"). The RSUs will vest in equal annual installments on March 2 of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates."}],"balance_after":779858,"source":{"system":"sec-edgar","filing":"0001299130-22-000033","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913022000033/certent-form4.xml","form_type":"4"}},{"id":2381901,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Commons Stock","published_at":"2022-02-22T21:44:52.000Z","date":"2022-02-17","kind":"sale","acquired":false,"shares":2122,"price":11.09,"value":23532.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This sale price represents the weighted average sale price of the shares sold ranging from $11.08 to $11.10 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4."}],"balance_after":672358,"source":{"system":"sec-edgar","filing":"0001299130-22-000024","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913022000024/certent-form4.xml","form_type":"4"}},{"id":2563906,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-09-21T01:44:49.000Z","date":"2021-09-16","kind":"grant","acquired":true,"shares":234548,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects earn-out shares that will vest in four substantially equal installments if the Issuer's Class A Common Stock achieves a price per share for any period of 20 trading days out of 30 consecutive trading days prior to September 16, 2026 that equals or exceeds the following thresholds: $12.50, $15.00, $17.50 and $20.00."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. (\"Legacy Ginkgo\"), as contemplated by an agreement and plan of merger, dated May 11, 2021 as amended on May 14, 2021 (the \"Merger Agreement\"), each share of Class A common stock of Legacy Ginkgo, each share of Class B common stock of Legacy Ginkgo, each option of Legacy Ginkgo under Legacy Ginkgo's stock incentive plans, each award of restricted common stock of Legacy Ginkgo under Legacy Ginkgo's stock incentive plans, and each award of restricted stock units of Legacy Ginkgo under Legacy Ginkgo's stock incentive plans, in each case outstanding immediately prior to the effective time of the business combination, received a proportional amount of the approximately 188.7 million earn-out shares."}],"balance_after":234548,"source":{"system":"sec-edgar","filing":"0000899243-21-036675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000089924321036675/doc4.xml","form_type":"4"}},{"id":2563935,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-09-21T01:40:28.000Z","date":"2021-09-16","kind":"sale","acquired":false,"shares":90520,"price":26.91,"value":2435893.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This sale price represents the weighted average sale price of the shares sold ranging from $26.72 to $27.08 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4/A."}],"balance_after":674480,"source":{"system":"sec-edgar","filing":"0001299130-21-000204","document":"certent-form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913021000204/certent-form4a.xml","form_type":"4/A","original_submission_date":"2021-09-17"}},{"id":2565458,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-09-17T20:53:54.000Z","date":"2021-09-16","kind":"sale","acquired":false,"shares":90520,"price":26.91,"value":2435893.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":674480,"source":{"system":"sec-edgar","filing":"0001299130-21-000198","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913021000198/certent-form4.xml","form_type":"4"}},{"id":2597550,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2021-08-18T22:08:31.000Z","date":"2021-08-16","kind":"grant","acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 12.5% of the shares in equal quarterly installments over the two-year period following the grant date on August 16, 2021."}],"balance_after":42000,"derivative":{"exercise_price":5.97,"expiration_date":"2026-08-16","underlying":"Ordinary Shares","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0000899243-21-033520","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000089924321033520/doc4.xml","form_type":"4"}},{"id":2849595,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-19T02:42:41.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal monthly installments over the next four years, provided that the Reporting Person continues to serve through each vesting date."}],"balance_after":30000,"derivative":{"exercise_price":46.37,"exercise_date":"2022-02-16","expiration_date":"2031-02-16","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001299130-21-000066","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913021000066/certent-form4.xml","form_type":"4"}},{"id":2849594,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-02-19T02:42:41.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\"). The RSUs will vest in equal annual installments on February 16 of each of 2022, 2023, 2024, and 2025, provided that the Reporting Person continues to serve through each vesting date."}],"balance_after":765000,"source":{"system":"sec-edgar","filing":"0001299130-21-000066","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913021000066/certent-form4.xml","form_type":"4"}},{"id":3028109,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-09-17T20:07:43.000Z","date":"2020-09-15","kind":"grant","acquired":true,"shares":1500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the option will vest on the one year anniversary of the date of grant, and the balance of shares will vest monthly thereafter over the next three years, provided that the Reporting Person continues to serve through each vesting date."}],"balance_after":1500000,"derivative":{"exercise_price":7.32,"exercise_date":"2021-09-15","expiration_date":"2030-09-15","underlying":"Common Stock","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0001209191-20-050870","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000120919120050870/doc4.xml","form_type":"4"}},{"id":3028108,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-09-17T20:07:43.000Z","date":"2020-09-15","kind":"grant","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\"). The RSUs will vest in equal annual installments on September 15 of each of 2021, 2022, 2023, and 2024, provided that the Reporting Person continues to serve through each vesting date."}],"balance_after":750000,"source":{"system":"sec-edgar","filing":"0001209191-20-050870","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000120919120050870/doc4.xml","form_type":"4"}},{"id":3050898,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2020-08-20T22:28:46.000Z","date":"2020-08-18","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2021 annual general meeting or August 18, 2021."}],"balance_after":10500,"derivative":{"exercise_price":9.13,"expiration_date":"2025-08-18","underlying":"Ordinary Shares","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0000899243-20-023078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000089924320023078/doc4.xml","form_type":"4"}},{"id":3065765,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman"}}],"security":"Stock Option (right to buy)","published_at":"2020-08-06T22:43:51.000Z","date":"2020-08-04","kind":"grant","acquired":true,"shares":97785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one year period, or if earlier, on the date of the Issuer's next annual meeting of stockholders, provided that the Reporting Person continues to serve as a director through each vesting date."}],"balance_after":97785,"derivative":{"exercise_price":3.89,"exercise_date":"2020-09-04","expiration_date":"2030-08-04","underlying":"Common Stock","underlying_shares":97785},"source":{"system":"sec-edgar","filing":"0001209191-20-045569","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000120919120045569/doc4.xml","form_type":"4"}},{"id":3208593,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman"}}],"security":"Stock Option (right to buy)","published_at":"2020-03-16T21:08:03.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3 of the shares subject to the option will vest on the one year anniversary of the date of grant, and the balance of shares will vest monthly thereafter over the next two years, provided that the Reporting Person continues to serve as a director through each vesting date."}],"balance_after":35000,"derivative":{"exercise_price":2.45,"exercise_date":"2021-03-16","expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-20-019320","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000120919120019320/doc4.xml","form_type":"4"}},{"id":3435942,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2019-08-16T20:21:30.000Z","date":"2019-08-15","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2020 annual general meeting or August 15, 2020."}],"balance_after":10500,"derivative":{"exercise_price":20.34,"expiration_date":"2024-08-15","underlying":"Ordinary Shares","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0000899243-19-021966","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000089924319021966/doc4.xml","form_type":"4"}},{"id":3843181,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2018-08-16T00:10:29.000Z","date":"2018-08-13","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on August 13, 2019."}],"balance_after":9000,"derivative":{"exercise_price":46.7,"expiration_date":"2023-08-13","underlying":"Ordinary Shares","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0000899243-18-022514","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000089924318022514/doc4.xml","form_type":"4"}},{"id":3857752,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-07-31T20:07:07.000Z","date":"2018-07-27","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3 of the shares subject to the option will vest on the one year anniversary of the date of grant, and the balance of shares will vest monthly thereafter over the next two years, provided that the Reporting Person continues to serve as a director through each vesting date."}],"balance_after":35000,"derivative":{"exercise_price":3.66,"expiration_date":"2028-07-27","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-18-044539","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000120919118044539/doc4.xml","form_type":"4"}},{"id":4230532,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2017-08-17T20:18:54.000Z","date":"2017-08-10","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on August 10, 2018."}],"balance_after":9000,"derivative":{"exercise_price":18.1,"expiration_date":"2022-08-10","underlying":"Ordinary Shares","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0000899243-17-020600","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000089924317020600/doc4.xml","form_type":"4"}},{"id":4475582,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"officer":true,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2017-02-01T00:29:13.000Z","date":"2017-01-30","kind":"tax_withholding","acquired":false,"shares":795,"price":159.28,"value":126627.6,"ownership":{"direct":true},"balance_after":17531,"source":{"system":"sec-edgar","filing":"0001127602-17-003220","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760217003220/form4.xml","form_type":"4"}},{"id":4557546,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2016-11-14T22:53:24.000Z","date":"2016-11-10","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 25% of the shares on November 10, 2017 and vests as to an additional 2.0833% of the shares monthly thereafter until November 10, 2020."}],"balance_after":18000,"derivative":{"exercise_price":36.43,"expiration_date":"2021-11-10","underlying":"Ordinary Shares","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0000899243-16-033365","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000089924316033365/doc4.xml","form_type":"4"}},{"id":4564248,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"officer":true,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2016-11-09T01:31:03.000Z","date":"2016-11-07","kind":"tax_withholding","acquired":false,"shares":650,"price":137.08,"value":89102.0,"ownership":{"direct":true},"balance_after":18326,"source":{"system":"sec-edgar","filing":"0001127602-16-066463","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760216066463/form4.xml","form_type":"4"}}]}